等待开盘 09-20 09:30:00 美东时间
+1.140
+4.68%
多只医药股狂飙!生物制药公司SMMT飙升56%,年内累涨633%,公司肺癌新药临床试验结果优异;TVTX大涨17%,公司的肾病药物获得FDA完全批准>>
09-10 16:11
Ami Fadia, an analyst from Needham, maintained the Buy rating on Bicycle Therap...
09-09 23:45
Cantor Fitzgerald analyst Li Watsek reiterates Bicycle Therapeutics (NASDAQ:BCYC) with a Overweight.
09-09 20:55
RBC Capital initiates coverage on Bicycle Therapeutics, highlighting Zelenectide's potential in oncology with improved safety over competitors. The analyst projects ~$2 billion in peak sales by 2033 and sees opportunities beyond metastatic urothelial cancer.
09-07 01:37
ADC药物作为现在最主流的偶联疗法,正在肿瘤治疗中呈现烈火烹油之势。但市场代有新药出,ADC也终将会被新的偶联疗法迭代。目前来看,这个迭代趋势正在显著加快。 多...
09-02 19:26
B. Riley Securities analyst Kalpit Patel downgrades Bicycle Therapeutics (NASDAQ:BCYC) from Buy to Neutral and lowers the price target from $33 to $28.
08-07 17:55
Bicycle Therapeutics (BCYC – Research Report), the Healthcare sector company, w...
08-07 16:56
In a report released today, Tara Bancroft from TD Cowen maintained a Buy rating...
08-06 22:11
①受Alphabet首次派息推动 美股二季度净股息增长160.5亿美元 标普道琼斯指数的数据显示,二季度美国国内普通股净股息变化增加了160.5亿美元,而前一季...
07-05 09:59
富国银行发布了其年度生物制药行业潜在并购清单,将减肥药开发商Viking Therapeutics(VKTX.US)、基因编辑公司CRISPR Therape...
05-27 11:21